Filing Flows › Arcus Biosciences (RCUS) › License and development services revenue
Arcus Biosciences (RCUS) License and development services revenue by quarter
Arcus Biosciences' License and development services revenue was $8.0M in Q3 2026 (third quarter 2026), -50% from Q2 2026. Over the last 3 quarters it ranged from $8.0M (Q3 2026) to $16.0M (Q2 2026).
| Quarter | License and development services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.0M | -50% | — |
| Q2 2026 | $16.0M | +33% | — |
| Q1 2026 | $12.0M | — | — |
Q3 2026 at a glance
Arcus Biosciences, Q3 2026: revenue $9.0M (-65% year over year), net loss $128M, operating cash flow −$88.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcus Biosciences' License and development services revenue?
Arcus Biosciences' License and development services revenue was $8.0M in Q3 2026 (third quarter 2026), -50% from Q2 2026.
How has Arcus Biosciences' License and development services revenue changed?
Over the last 3 quarters it ranged from $8.0M (Q3 2026) to $16.0M (Q2 2026).